We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Melatonin Promotes Oligodendroglial Maturation of Injured White Matter in Neonatal Rats.
- Authors
Olivier, Paul; Fontaine, Romain H.; Loron, Gauthier; van Steenwinckel, Juliette; Biran, Valérie; Massonneau, Véronique; Kaindl, Angela; Dalous, Jeremie; Charriaut-Marlangue, Christiane; Aigrot, Marie-Stéphane; Pansiot, Julien; Verney, Catherine; Gressens, Pierre; Baud, Olivier
- Abstract
Objective: To investigate the effects of melatonin treatment in a rat model of white matter damage (WMD) in the developing brain. Additionally, we aim to delineate the cellular mechanisms of melatonin effect on the oligodendroglial cell lineage. Methods: A unilateral ligation of the uterine artery in pregnant rat at the embryonic day 17 induces fetal hypoxia and subsequent growth restriction (GR) in neonatal pups. GR and control pups received a daily intra-peritoneal injection of melatonin from birth to post-natal day (P) 3. Results: Melatonin administration was associated with a dramatic decrease in microglial activation and astroglial reaction compared to untreated GR pups. At P14, melatonin prevented white matter myelination defects with an increased number of mature oligodendrocytes (APC-immunoreactive) in treated GR pups. Conversely, melatonin was not found to be associated with an increased density of total oligodendrocytes (Olig2-immunoreactive), suggesting that melatonin is able to promote oligodendrocyte maturation but not proliferation. These effects appear to be melatonin-receptor dependent and were reproduced in vitro. Interpretation: These data suggest that melatonin has a strong protective effect on developing damaged white matter through decreased microglial activation and oligodendroglial maturation leading to a normalization of the myelination process. Consequently, melatonin should be a considered as an effective neuroprotective candidate not only in perinatal brain damage but also in inflammatory and demyelinating diseases observed in adults.
- Subjects
MELATONIN; LABORATORY mice; NEURAL development; UTERINE artery; LABORATORY rats; FETAL anoxia; MYELINATION; NEUROPROTECTIVE agents; THERAPEUTICS
- Publication
PLoS ONE, 2009, Vol 4, Issue 9, p1
- ISSN
1932-6203
- Publication type
Article
- DOI
10.1371/journal.pone.0007128